James Collins

James Collins

Director/Board Member at SENTI BIOSCIENCES, INC.

Net worth: 288 911 $ as of 2024-03-30

58 year
Health Technology
Commercial Services
Consumer Services

Profile

James J.
Collins
is the founder of Cellicon Biotechnologies, Inc. (founded in 2000), Corvium, Inc. (founded in 2009), Synlogic Operating Co., Inc. (founded in 2014), EnBiotix, Inc. (founded in 2012), Senti Sub I, Inc. (founded in 2016), Synlogic, Inc. (founded in 2017), Sherlock Biosciences, Inc. (founded in 2018), and Cellarity Inc. (founded in 2017).
He currently holds the position of Independent Director at Fulcrum Therapeutics, Inc. (since 2017), Independent Director at Orion Biotech Opportunities Corp., Independent Director at Senti Biosciences, Inc. (since 2022), Professor at Harvard University, Professor at Massachusetts Institute of Technology (since 2014), and Member of the National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Engineering, National Academy of Medicine (United States), Excel Medical Ventures LLC (Board of Strategic Advisors), The Broad Institute, Inc., Harvard Mit Health Sciences & Technology, and National Academy of Inventors.
He previously held the position of Chief Scientific Officer at Aitia, Inc. (from 2008 to 2012) and Professor at Boston University (from 1990 to 2014).
He completed his undergraduate degree at the College of the Holy Cross (Massachusetts) and obtained a doctorate degree from the University of Oxford.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-26 23,571 ( 0.04% ) 222 510 $ 2024-03-30
2023-06-15 176,130 ( 0.38% ) 66 401 $ 2024-03-30

James Collins active positions

CompaniesPositionStart
ORION BIOTECH OPPORTUNITIES CORP. Director/Board Member -
FULCRUM THERAPEUTICS, INC. Director/Board Member 2016-12-31
SENTI BIOSCIENCES, INC. Director/Board Member 2022-06-07
Massachusetts Institute of Technology Corporate Officer/Principal 2014-11-30
Corporate Officer/Principal -
Director/Board Member -
Harvard Mit Health Sciences & Technology Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
All active positions of James Collins

Former positions of James Collins

CompaniesPositionEnd
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
See the detail of James Collins's experience

Training of James Collins

College of the Holy Cross (Massachusetts) Undergraduate Degree
University of Oxford Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Collins's experience

Connections

100 +

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
FULCRUM THERAPEUTICS, INC.

Health Technology

SYNLOGIC, INC.

Health Technology

SENTI BIOSCIENCES, INC.

Health Technology

Private companies16

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Finance

Health Technology

Technology Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

See company connections